CircATF6 acts as a scaffold to form a circATF6/CALR/CAPN2 ternary complex, facilitating degradation of CALR (Calreticulin) by CAPN2 (Calpain 2), thereby inhibiting HCC progression (43). This evidence concerns the gene CALR and hepatocellular carcinoma.